Proactive Investors
10 Sept 2026, 09:29 UTC · 1d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
5 claims · each scored for market impact
Jefferies maintained a 'buy' rating and a 1,100p price target for Fevertree Drinks following strong H1 results. — Positive analyst validation and a specific price target typically drive investor confidence and upward price movement for small-cap stocks.
+0.60Fevertree's US off-trade sales growth accelerated from 6% in Q1 to 11% in Q2 and 16% in Q3. — Consistent acceleration in the critical US market suggests strong momentum and successful execution of the Molson Coors partnership.
+0.50Jefferies increased Fevertree's 2026 EPS estimate by 3% and its 2027 forecast by approximately 5%. — Upward revisions to earnings per share (EPS) forecasts generally lead to higher stock valuations.
+0.40Continue reading
5 related stories
Top 1 mover · tap to explore
Sunda Energy PLC expects its New Zealand acquisition to complete around late September or early October. — The completion of an acquisition adding producing assets (1,000+ boe/d) is a material growth catalyst for the company.
+0.30Non-tonic products now account for 47% of Fevertree's group sales. — Successful diversification reduces reliance on a single product category and lowers business risk.
+0.20Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
CNBC
35m ago
